{"pmid":32187007,"title":"Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","text":["Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks.","Emerg Infect Dis","Frieden, Thomas R","Lee, Christopher T","32187007"],"abstract":["It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks."],"journal":"Emerg Infect Dis","authors":["Frieden, Thomas R","Lee, Christopher T"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32187007","week":"202012|Mar 16 - Mar 22","doi":"10.3201/eid2606.200495","keywords":["2019 novel coronavirus disease","COVID-19","SARS-CoV-2","SSEs","behavioral factors","coronavirus","disease control","environmental factors","host factors","outbreaks","pathogen-specific factors","respiratory infections","response factors","severe acute respiratory syndrome coronavirus 2","superspreading events","viruses","zoonoses"],"source":"PubMed","topics":["Transmission"],"weight":1,"_version_":1661633092446584832,"score":6.786717,"similar":[{"pmid":32131151,"title":"[Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19].","text":["[Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19].","Objective: To investigate the mental health of clinical first-line medical staff in COVID-19 epidemic and provide theoretical basis for psychological intervention. Method: The mental health status of the first-line medical staff was investigated by Self-rating Anxiety Acale (SAS) and Post-Traumatic Stress Disorder Self-rating Scale(PTSD-SS). From February 7 to 14, 2020, 246 medical staff were investigated who participated in the treatment of COVID-19 using cluster sampling , and received 230 responses, with a recovery rate of 93.5%. Results: The incidence of anxiety in medical staff was 23.04% (53/230), and the score of SAS was (42.91 +/- 10.89). Among them, the incidence of severe anxiety, moderate anxiety and mild anxiety were 2.17% (5/230), 4.78% (11/230) and 16.09% (37/230), respectively. The incidence of anxiety in female medical staff was higher than that in male [25.67% (48/187) vs 11.63% (5/43), Z=-2.008, P=0.045], the score of SAS in female medical staff was higher than that in male [(43.78+/-11.12) vs (39.14 +/- 9.01), t =-2.548, P=0.012]. The incidence of anxiety in nurses was higher than that in doctors [26.88% (43/160) vs 14.29% (10/70), Z=-2.066, P=0.039], and the score of SAS in nurses was higher than that in doctors [(44.84+/-10.42) vs (38.50+/-10.72), t =-4.207, P<0.001]. The incidence of stress disorder in medical staff was 27.39% (63/230), and the score of PTSD-SS was (42.92 +/- 17.88). The score of PTSD-SS in female medical staff was higher than that of male [(44.30+/-18.42) vs(36.91 +/- 13.95), t=-2.472, P=0.014]. Conclusions: In COVID-19 epidemic, the incidence of anxiety and stress disorder is high among medical staff. Medical institutions should strengthen the training of psychological skills of medical staff. Special attention should be paid to the mental health of female nurses.","Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi","Huang, J Z","Han, M F","Luo, T D","Ren, A K","Zhou, X P","32131151"],"abstract":["Objective: To investigate the mental health of clinical first-line medical staff in COVID-19 epidemic and provide theoretical basis for psychological intervention. Method: The mental health status of the first-line medical staff was investigated by Self-rating Anxiety Acale (SAS) and Post-Traumatic Stress Disorder Self-rating Scale(PTSD-SS). From February 7 to 14, 2020, 246 medical staff were investigated who participated in the treatment of COVID-19 using cluster sampling , and received 230 responses, with a recovery rate of 93.5%. Results: The incidence of anxiety in medical staff was 23.04% (53/230), and the score of SAS was (42.91 +/- 10.89). Among them, the incidence of severe anxiety, moderate anxiety and mild anxiety were 2.17% (5/230), 4.78% (11/230) and 16.09% (37/230), respectively. The incidence of anxiety in female medical staff was higher than that in male [25.67% (48/187) vs 11.63% (5/43), Z=-2.008, P=0.045], the score of SAS in female medical staff was higher than that in male [(43.78+/-11.12) vs (39.14 +/- 9.01), t =-2.548, P=0.012]. The incidence of anxiety in nurses was higher than that in doctors [26.88% (43/160) vs 14.29% (10/70), Z=-2.066, P=0.039], and the score of SAS in nurses was higher than that in doctors [(44.84+/-10.42) vs (38.50+/-10.72), t =-4.207, P<0.001]. The incidence of stress disorder in medical staff was 27.39% (63/230), and the score of PTSD-SS was (42.92 +/- 17.88). The score of PTSD-SS in female medical staff was higher than that of male [(44.30+/-18.42) vs(36.91 +/- 13.95), t=-2.472, P=0.014]. Conclusions: In COVID-19 epidemic, the incidence of anxiety and stress disorder is high among medical staff. Medical institutions should strengthen the training of psychological skills of medical staff. Special attention should be paid to the mental health of female nurses."],"journal":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi","authors":["Huang, J Z","Han, M F","Luo, T D","Ren, A K","Zhou, X P"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32131151","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn121094-20200219-00063","keywords":["Anxiety","COVID-19","Medical staff","Stress disorder, post-traumatic"],"source":"PubMed","locations":["Z=-2.066","Z=-2.008"],"topics":["General Info"],"weight":1,"_version_":1661359647684034560,"score":220.57764},{"pmid":32160149,"title":"Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States.","The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures.","Emerg Infect Dis","Harcourt, Jennifer","Tamin, Azaibi","Lu, Xiaoyan","Kamili, Shifaq","Sakthivel, Senthil K","Murray, Janna","Queen, Krista","Tao, Ying","Paden, Clinton R","Zhang, Jing","Li, Yan","Uehara, Anna","Wang, Haibin","Goldsmith, Cynthia","Bullock, Hannah A","Wang, Lijuan","Whitaker, Brett","Lynch, Brian","Gautam, Rashi","Schindewolf, Craig","Lokugamage, Kumari G","Scharton, Dionna","Plante, Jessica A","Mirchandani, Divya","Widen, Steven G","Narayanan, Krishna","Makino, Shinji","Ksiazek, Thomas G","Plante, Kenneth S","Weaver, Scott C","Lindstrom, Stephen","Tong, Suxiang","Menachery, Vineet D","Thornburg, Natalie J","32160149"],"abstract":["The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures."],"journal":"Emerg Infect Dis","authors":["Harcourt, Jennifer","Tamin, Azaibi","Lu, Xiaoyan","Kamili, Shifaq","Sakthivel, Senthil K","Murray, Janna","Queen, Krista","Tao, Ying","Paden, Clinton R","Zhang, Jing","Li, Yan","Uehara, Anna","Wang, Haibin","Goldsmith, Cynthia","Bullock, Hannah A","Wang, Lijuan","Whitaker, Brett","Lynch, Brian","Gautam, Rashi","Schindewolf, Craig","Lokugamage, Kumari G","Scharton, Dionna","Plante, Jessica A","Mirchandani, Divya","Widen, Steven G","Narayanan, Krishna","Makino, Shinji","Ksiazek, Thomas G","Plante, Kenneth S","Weaver, Scott C","Lindstrom, Stephen","Tong, Suxiang","Menachery, Vineet D","Thornburg, Natalie J"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32160149","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200516","keywords":["2019 novel coronavirus disease","COVID-19","PCR","SARS-CoV-2","United States","characterization","coronavirus","isolation","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","locations":["Washington","United States","Wuhan","China"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1661359647848660992,"score":218.59375},{"pmid":32168464,"title":"Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","text":["Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control.","Emerg Infect Dis","Mizumoto, Kenji","Chowell, Gerardo","32168464"],"abstract":["Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control."],"journal":"Emerg Infect Dis","authors":["Mizumoto, Kenji","Chowell, Gerardo"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168464","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200233","keywords":["2019 novel coronavirus disease","CFR","COVID-19","China","Hubei","SARS-CoV-2","Wuhan","case-fatality ratio","coronavirus","death","mortality","outbreak","respiratory diseases","risk","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1661359647930449922,"score":189.51077},{"pmid":32168465,"title":"Epidemiology of 2019 Novel Coronavirus Disease-19 in Gansu Province, China, 2020.","text":["Epidemiology of 2019 Novel Coronavirus Disease-19 in Gansu Province, China, 2020.","To determine the epidemiology of 2019 novel coronavirus disease (COVID-19) in a remote region of China, far from Wuhan, we analyzed the epidemiology of COVID-19 in Gansu Province. From January 23 through February 3, 2020, a total of 35 (64.8%) of 54 reported cases were imported from COVID-19-epidemic areas. Characteristics that differed significantly during the first and second waves of illness in Gansu Province were mean patient age, occupation, having visited epidemic areas, and mode of transportation. Time from infection to illness onset for family clusters was shorter in Gansu Province than in Wuhan, consistent with shortened durations from onset to first medical visit or hospitalization. Spatial distribution pattern analysis indicated hot spots and spatial outliers in Gansu Province. As a result of adequate interventions, transmission of the COVID-19 virus in Gansu Province is decreasing.","Emerg Infect Dis","Fan, Jingchun","Liu, Xiaodong","Pan, Weimin","Douglas, Mark W","Bao, Shisan","32168465"],"abstract":["To determine the epidemiology of 2019 novel coronavirus disease (COVID-19) in a remote region of China, far from Wuhan, we analyzed the epidemiology of COVID-19 in Gansu Province. From January 23 through February 3, 2020, a total of 35 (64.8%) of 54 reported cases were imported from COVID-19-epidemic areas. Characteristics that differed significantly during the first and second waves of illness in Gansu Province were mean patient age, occupation, having visited epidemic areas, and mode of transportation. Time from infection to illness onset for family clusters was shorter in Gansu Province than in Wuhan, consistent with shortened durations from onset to first medical visit or hospitalization. Spatial distribution pattern analysis indicated hot spots and spatial outliers in Gansu Province. As a result of adequate interventions, transmission of the COVID-19 virus in Gansu Province is decreasing."],"journal":"Emerg Infect Dis","authors":["Fan, Jingchun","Liu, Xiaodong","Pan, Weimin","Douglas, Mark W","Bao, Shisan"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168465","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200251","keywords":["2019 novel coronavirus disease","COVID-19","China","Gansu Province","SARS-CoV-2","Wuhan","coronavirus","outbreaks","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","locations":["Gansu","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1661359647931498496,"score":179.56902},{"pmid":32057210,"title":"[The prevention and control of a new coronavirus infection in department of stomatology].","text":["[The prevention and control of a new coronavirus infection in department of stomatology].","During a short period of time, the outbreak of pneumonia caused by a novel coronavirus, named Novel Coronavirus Pneumonia (NCP), was first reported in China, spreading to 24 countries and regions rapidly. The number of confirmed cases and deaths continued to rise. World Health Organization (WHO) announced that the outbreaks of the novel coronavirus have constituted a Public Health Emergency of International Concern. Efficient infection control can prevent the virus from further spreading, which makes the epidemic situation under control. Due to the specialty of oral healthcare settings, the risk of cross infection is severe among patients and oral healthcare practitioners. It's more urgent to implement strict and efficient infection control protocols. This paper, based on existing guidelines and published researches pertinent to dental infection-control principles and practices, mainly discusses epidemiological characteristics of NCP and the features of nosocomial infection in oral healthcare settings, and furthermore provides recommendations on patient's evaluation, and infection control protocols in department of stomatology under current circumstance..","Zhonghua Kou Qiang Yi Xue Za Zhi","Li, Z Y","Meng, L Y","32057210"],"abstract":["During a short period of time, the outbreak of pneumonia caused by a novel coronavirus, named Novel Coronavirus Pneumonia (NCP), was first reported in China, spreading to 24 countries and regions rapidly. The number of confirmed cases and deaths continued to rise. World Health Organization (WHO) announced that the outbreaks of the novel coronavirus have constituted a Public Health Emergency of International Concern. Efficient infection control can prevent the virus from further spreading, which makes the epidemic situation under control. Due to the specialty of oral healthcare settings, the risk of cross infection is severe among patients and oral healthcare practitioners. It's more urgent to implement strict and efficient infection control protocols. This paper, based on existing guidelines and published researches pertinent to dental infection-control principles and practices, mainly discusses epidemiological characteristics of NCP and the features of nosocomial infection in oral healthcare settings, and furthermore provides recommendations on patient's evaluation, and infection control protocols in department of stomatology under current circumstance.."],"journal":"Zhonghua Kou Qiang Yi Xue Za Zhi","authors":["Li, Z Y","Meng, L Y"],"date":"2020-02-15T11:00:00Z","year":2020,"_id":"32057210","week":"20207|Feb 10 - Feb 16","doi":"10.3760/cma.j.issn.1002-0098.2020.0001","keywords":["Infection control","Novel coronavirus pneumonia","Pneumonia, viral","Stomatological practice"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1661359647279284224,"score":171.48946}]}